Report overview
Spironolactone(CAS?52-01-7) is a medication that is primarily used to treat fluid build-up due to heart failure, liver scarring, or kidney disease.
This report contains market size and forecasts of Spironolactone API in global, including the following market information:
Global Spironolactone API Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Spironolactone API Market Sales, 2018-2023, 2023-2030, (Kg)
Global top five Spironolactone API companies in 2022 (%)
The global Spironolactone API market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Above 98 % Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Spironolactone API include Otto Brandes, Dasami Lab, EUROAPI, Hetero Drugs, Intas Pharmaceuticals, Piramal Pharma Solutions, ZHEJIANG LANGHUA PHARMACEUTICAL, Yicheng Goto Pharmaceuticals and Zhejiang Shenzhou Pharmaceutical, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Spironolactone API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Spironolactone API Market, by Purity, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Spironolactone API Market Segment Percentages, by Purity, 2022 (%)
Above 98 %
Above 99 %
Global Spironolactone API Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Spironolactone API Market Segment Percentages, by Application, 2022 (%)
Tablets
Others
Global Spironolactone API Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Spironolactone API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Spironolactone API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Spironolactone API revenues share in global market, 2022 (%)
Key companies Spironolactone API sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Spironolactone API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Otto Brandes
Dasami Lab
EUROAPI
Hetero Drugs
Intas Pharmaceuticals
Piramal Pharma Solutions
ZHEJIANG LANGHUA PHARMACEUTICAL
Yicheng Goto Pharmaceuticals
Zhejiang Shenzhou Pharmaceutical
Tianjin Jinjin Pharmaceutical
Symbiotec Pharmalab
Nortec Quimica
Hanways Chempharm Co., Limited
Biotechnica Pharma Global
Asia Pioneer Pharmaceuticals
